BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 30047419)

  • 1. Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.
    Agarwal S
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):669-685. PubMed ID: 30047419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere length in inherited bone marrow failure syndromes.
    Alter BP; Giri N; Savage SA; Rosenberg PS
    Haematologica; 2015 Jan; 100(1):49-54. PubMed ID: 25304614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.
    Fok WC; Niero ELO; Dege C; Brenner KA; Sturgeon CM; Batista LFZ
    Stem Cell Reports; 2017 Aug; 9(2):409-418. PubMed ID: 28757166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
    Hoffman H; Rice C; Skordalakes E
    J Biol Chem; 2017 Mar; 292(11):4593-4601. PubMed ID: 28154186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.
    Niewisch MR; Savage SA
    Expert Rev Hematol; 2019 Dec; 12(12):1037-1052. PubMed ID: 31478401
    [No Abstract]   [Full Text] [Related]  

  • 6. Dyskeratosis congenita and telomere biology disorders.
    Savage SA
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):637-648. PubMed ID: 36485133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.
    Du HY; Pumbo E; Ivanovich J; An P; Maziarz RT; Reiss UM; Chirnomas D; Shimamura A; Vlachos A; Lipton JM; Goyal RK; Goldman F; Wilson DB; Mason PJ; Bessler M
    Blood; 2009 Jan; 113(2):309-16. PubMed ID: 18931339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyskeratosis congenita, stem cells and telomeres.
    Kirwan M; Dokal I
    Biochim Biophys Acta; 2009 Apr; 1792(4):371-9. PubMed ID: 19419704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The shelterin complex and hematopoiesis.
    Jones M; Bisht K; Savage SA; Nandakumar J; Keegan CE; Maillard I
    J Clin Invest; 2016 May; 126(5):1621-9. PubMed ID: 27135879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in dyskeratosis congenita.
    Nishio N; Kojima S
    Int J Hematol; 2010 Oct; 92(3):419-24. PubMed ID: 20882440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita.
    Beier F; Foronda M; Martinez P; Blasco MA
    Blood; 2012 Oct; 120(15):2990-3000. PubMed ID: 22932806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining the phenotype associated with biallelic DNAJC21 mutations.
    D'Amours G; Lopes F; Gauthier J; Saillour V; Nassif C; Wynn R; Alos N; Leblanc T; Capri Y; Nizard S; Lemyre E; Michaud JL; Pelletier VA; Pastore YD; Soucy JF
    Clin Genet; 2018 Aug; 94(2):252-258. PubMed ID: 29700810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxysmal nocturnal hemoglobinuria clones are not infrequent in patients with inherited bone marrow failure syndromes.
    Sreedharanunni S; Varma N; Sachdeva MUS; Naseem S; Malhotra P; Bansal D; Sood A; Bose P; Varma S
    Eur J Haematol; 2017 Aug; 99(2):194-195. PubMed ID: 28452421
    [No Abstract]   [Full Text] [Related]  

  • 14. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.
    Walne AJ; Vulliamy T; Beswick R; Kirwan M; Dokal I
    Blood; 2008 Nov; 112(9):3594-600. PubMed ID: 18669893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired and Inherited Bone Marrow Failure Syndromes.
    Sieff CA
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):xiii-xiv. PubMed ID: 30047424
    [No Abstract]   [Full Text] [Related]  

  • 16. Introduction to Acquired and Inherited Bone Marrow Failure.
    Sieff CA
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):569-580. PubMed ID: 30047411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric conditions among patients with dyskeratosis congenita: a link with telomere biology?
    Rackley S; Pao M; Seratti GF; Giri N; Rasimas JJ; Alter BP; Savage SA
    Psychosomatics; 2012; 53(3):230-5. PubMed ID: 22458992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow failure and the new telomere diseases: practice and research.
    Young NS
    Hematology; 2012 Apr; 17 Suppl 1():S18-21. PubMed ID: 22507770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita.
    Khincha PP; Bertuch AA; Gadalla SM; Giri N; Alter BP; Savage SA
    Blood Adv; 2018 Jun; 2(11):1243-1249. PubMed ID: 29853525
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.